
Keywords: AR; aldose reductase; ARIs; aldose reductase inhibitors; HNE; trans-4-hydroxy-2,3-nonenal; ARDIs; aldose reductase differential inhibitors; 2-ME; 2-mercaptoethanol; DTT; d,l-dithiothreitol; hAR; human placental recombinant aldose reductase; bAR; bovine le